Pharmaceutical Supply Chain Tackles Track-and-Trace Challenges

摘要

New legislation is in the works to prevent counterfeit medicines from entering the pharmaceutical supply chain. These random mixtures of harmful toxic substances are not only illegal; they are extremely dangerous to patients and damaging to the reputations of legitimate pharmaceutical companies.